Elevance Health Statistics
Share Statistics
Elevance Health has 231.92M shares outstanding. The number of shares has increased by -0.32% in one year.
| Shares Outstanding | 231.92M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.02% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 231.44M |
| Failed to Deliver (FTD) Shares | 232 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 3.45M, so 1.49% of the outstanding shares have been sold short.
| Short Interest | 3.45M |
| Short % of Shares Out | 1.49% |
| Short % of Float | 1.49% |
| Short Ratio (days to cover) | 1.82 |
Valuation Ratios
The PE ratio is 18.36 and the forward PE ratio is 11.81. Elevance Health 's PEG ratio is 0.23.
| PE Ratio | 18.36 |
| Forward PE | 11.81 |
| PS Ratio | 0.64 |
| Forward PS | 0.4 |
| PB Ratio | 2.8 |
| P/FCF Ratio | 16.25 |
| PEG Ratio | 0.23 |
Enterprise Valuation
Elevance Health Inc. has an Enterprise Value (EV) of 129.84B.
| EV / Earnings | 21.69 |
| EV / Sales | 0.76 |
| EV / EBITDA | 12.38 |
| EV / EBIT | 14.85 |
| EV / FCF | 19.19 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.64.
| Current Ratio | 1.44 |
| Quick Ratio | 1.44 |
| Debt / Equity | 0.64 |
| Total Debt / Capitalization | 38.99 |
| Cash Flow / Debt | 0.32 |
| Interest Coverage | 8.49 |
Financial Efficiency
Return on equity (ROE) is 0.15% and return on capital (ROIC) is 10.52%.
| Return on Equity (ROE) | 0.15% |
| Return on Assets (ROA) | 0.05% |
| Return on Capital (ROIC) | 10.52% |
| Revenue Per Employee | 1.63M |
| Profits Per Employee | 57.07K |
| Employee Count | 104.90K |
| Asset Turnover | 1.57 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 1.72B |
| Effective Tax Rate | 0.22 |
Stock Price Statistics
The stock price has increased by -20.98% in the last 52 weeks. The beta is 0.85, so Elevance Health 's price volatility has been higher than the market average.
| Beta | 0.85 |
| 52-Week Price Change | -20.98% |
| 50-Day Moving Average | 396 |
| 200-Day Moving Average | 492.42 |
| Relative Strength Index (RSI) | 47.38 |
| Average Volume (20 Days) | 1.96M |
Income Statement
In the last 12 months, Elevance Health had revenue of 171.34B and earned 5.99B in profits. Earnings per share was 25.69.
| Revenue | 171.34B |
| Gross Profit | 47.01B |
| Operating Income | 8.74B |
| Net Income | 5.99B |
| EBITDA | 10.49B |
| EBIT | 8.74B |
| Earnings Per Share (EPS) | 25.69 |
Balance Sheet
The company has 6.53B in cash and 25.12B in debt, giving a net cash position of -18.59B.
| Cash & Cash Equivalents | 6.53B |
| Total Debt | 25.12B |
| Net Cash | -18.59B |
| Retained Earnings | 31.75B |
| Total Assets | 116.53B |
| Working Capital | 20.81B |
Cash Flow
In the last 12 months, operating cash flow was 8.06B and capital expenditures -1.30B, giving a free cash flow of 6.76B.
| Operating Cash Flow | 8.06B |
| Capital Expenditures | -1.30B |
| Free Cash Flow | 6.76B |
| FCF Per Share | 29.03 |
Margins
Gross margin is 2.74K%, with operating and profit margins of 510% and 349%.
| Gross Margin | 2.74K% |
| Operating Margin | 510% |
| Pretax Margin | 450% |
| Profit Margin | 349% |
| EBITDA Margin | 6.12% |
| EBIT Margin | 5.1% |
| FCF Margin | 3.95% |
Dividends & Yields
ELV pays an annual dividend of $6.52, which amounts to a dividend yield of 1.75%.
| Dividend Per Share | $6.52 |
| Dividend Yield | 1.75% |
| Dividend Growth (YoY) | 10.14% |
| Payout Ratio | 23.73% |
| Earnings Yield | 6.77% |
| FCF Yield | 7.69% |
Analyst Forecast
The average price target for ELV is $517.5, which is 36.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $517.5 |
| Price Target Difference | 36.4% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
Stock Splits
The last stock split was on Jun 1, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2005 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 3.11 |
| Piotroski F-Score | 6 |